360 related articles for article (PubMed ID: 24532983)
1. Mutations in PRKN and SNCA Genes Important for the Progress of Parkinson's Disease.
Oczkowska A; Kozubski W; Lianeri M; Dorszewska J
Curr Genomics; 2013 Dec; 14(8):502-17. PubMed ID: 24532983
[TBL] [Abstract][Full Text] [Related]
2. Oxidative stress factors in Parkinson's disease.
Dorszewska J; Kowalska M; Prendecki M; Piekut T; Kozłowska J; Kozubski W
Neural Regen Res; 2021 Jul; 16(7):1383-1391. PubMed ID: 33318422
[TBL] [Abstract][Full Text] [Related]
3. Analysis of PRKN Variants and Clinical Features in Polish Patients with Parkinson's Disease.
Oczkowska A; Florczak-Wyspianska J; Permoda-Osip A; Owecki M; Lianeri M; Kozubski W; Dorszewska J
Curr Genomics; 2015 Aug; 16(4):215-23. PubMed ID: 27006626
[TBL] [Abstract][Full Text] [Related]
4. Analysis of α-syn and
Narwal S; Singh A; Tare M
Front Cell Neurosci; 2023; 17():1295805. PubMed ID: 38239290
[TBL] [Abstract][Full Text] [Related]
5. Mutation analysis of the PARKIN, PINK1, DJ1, and SNCA genes in Turkish early-onset Parkinson's patients and genotype-phenotype correlations.
Erer S; Egeli U; Zarifoglu M; Tezcan G; Cecener G; Tunca B; Ak S; Demirdogen E; Kenangil G; Kaleagası H; Dogu O; Saka E; Elibol B
Clin Neurol Neurosurg; 2016 Sep; 148():147-53. PubMed ID: 27455133
[TBL] [Abstract][Full Text] [Related]
6. Genetic analysis of Mendelian mutations in a large UK population-based Parkinson's disease study.
Tan MMX; Malek N; Lawton MA; Hubbard L; Pittman AM; Joseph T; Hehir J; Swallow DMA; Grosset KA; Marrinan SL; Bajaj N; Barker RA; Burn DJ; Bresner C; Foltynie T; Hardy J; Wood N; Ben-Shlomo Y; Grosset DG; Williams NM; Morris HR
Brain; 2019 Sep; 142(9):2828-2844. PubMed ID: 31324919
[TBL] [Abstract][Full Text] [Related]
7. [Alpha-synuclein in Parkinson's disease].
Oczkowska A; Kozubski W; Dorszewska J
Przegl Lek; 2014; 71(1):26-32. PubMed ID: 24712265
[TBL] [Abstract][Full Text] [Related]
8. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
Hattori N
Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
[TBL] [Abstract][Full Text] [Related]
9. Somatic copy number gains of α-synuclein (SNCA) in Parkinson's disease and multiple system atrophy brains.
Mokretar K; Pease D; Taanman JW; Soenmez A; Ejaz A; Lashley T; Ling H; Gentleman S; Houlden H; Holton JL; Schapira AHV; Nacheva E; Proukakis C
Brain; 2018 Aug; 141(8):2419-2431. PubMed ID: 29917054
[TBL] [Abstract][Full Text] [Related]
10. The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson's disease.
Yasuda T; Mochizuki H
Apoptosis; 2010 Nov; 15(11):1312-21. PubMed ID: 20221696
[TBL] [Abstract][Full Text] [Related]
11. Effect of allelic variation at the NACP-Rep1 repeat upstream of the alpha-synuclein gene (SNCA) on transcription in a cell culture luciferase reporter system.
Chiba-Falek O; Nussbaum RL
Hum Mol Genet; 2001 Dec; 10(26):3101-9. PubMed ID: 11751692
[TBL] [Abstract][Full Text] [Related]
12. Role of LRRK2 and SNCA in autosomal dominant Parkinson's disease in Turkey.
Kessler C; Atasu B; Hanagasi H; Simón-Sánchez J; Hauser AK; Pak M; Bilgic B; Erginel-Unaltuna N; Gurvit H; Gasser T; Lohmann E
Parkinsonism Relat Disord; 2018 Mar; 48():34-39. PubMed ID: 29248340
[TBL] [Abstract][Full Text] [Related]
13. Heredity in Parkinson's disease: new findings.
Lev N; Melamed E
Isr Med Assoc J; 2001 Jun; 3(6):435-8. PubMed ID: 11433638
[TBL] [Abstract][Full Text] [Related]
14. Parkin mRNA Expression Levels in Peripheral Blood Mononuclear Cells in Parkin-Related Parkinson's Disease.
Papagiannakis N; Liu H; Koros C; Simitsi AM; Stamelou M; Maniati M; Buena-Atienza E; Kartanou C; Karadima G; Makrythanasis P; Vatsellas G; Valente EM; Gasser T; Stefanis L
Mov Disord; 2024 Apr; 39(4):715-722. PubMed ID: 38357851
[TBL] [Abstract][Full Text] [Related]
15. Parkin is transcriptionally regulated by the aryl hydrocarbon receptor: Impact on α-synuclein protein levels.
González-Barbosa E; García-Aguilar R; Vega L; Cabañas-Cortés MA; Gonzalez FJ; Segovia J; Morales-Lázaro SL; Cisneros B; Elizondo G
Biochem Pharmacol; 2019 Oct; 168():429-437. PubMed ID: 31404530
[TBL] [Abstract][Full Text] [Related]
16. Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease.
Benitez BA; Davis AA; Jin SC; Ibanez L; Ortega-Cubero S; Pastor P; Choi J; Cooper B; Perlmutter JS; Cruchaga C
Mol Neurodegener; 2016 Apr; 11():29. PubMed ID: 27094865
[TBL] [Abstract][Full Text] [Related]
17. α-synuclein expression from a single copy transgene increases sensitivity to stress and accelerates neuronal loss in genetic models of Parkinson's disease.
Cooper JF; Spielbauer KK; Senchuk MM; Nadarajan S; Colaiácovo MP; Van Raamsdonk JM
Exp Neurol; 2018 Dec; 310():58-69. PubMed ID: 30194957
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional alterations in skin fibroblasts from Parkinson's disease patients with parkin mutations.
González-Casacuberta I; Morén C; Juárez-Flores DL; Esteve-Codina A; Sierra C; Catalán-García M; Guitart-Mampel M; Tobías E; Milisenda JC; Pont-Sunyer C; Martí MJ; Cardellach F; Tolosa E; Artuch R; Ezquerra M; Fernández-Santiago R; Garrabou G
Neurobiol Aging; 2018 May; 65():206-216. PubMed ID: 29501959
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective Effect of Natural Indole and β-carboline Alkaloids against Parkinson's Disease: An Overview.
Shome A; Chahat ; Chawla V; Chawla PA
Curr Med Chem; 2023 Sep; ():. PubMed ID: 37702172
[TBL] [Abstract][Full Text] [Related]
20. Diversity of pathological features other than Lewy bodies in familial Parkinson's disease due to SNCA mutations.
Fujishiro H; Imamura AY; Lin WL; Uchikado H; Mark MH; Golbe LI; Markopoulou K; Wszolek ZK; Dickson DW
Am J Neurodegener Dis; 2013; 2(4):266-75. PubMed ID: 24319644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
